Recipient aging accelerates acquired transthyretin amyloidosis after domino liver transplantation
Yohei Misumi, Yasuko Narita, Toshinori Oshima, Mitsuharu Ueda, Taro Yamashita, Masayoshi Tasaki, Konen Obayashi, Kaori Isono, Yukihiro Inomata, Yukio Ando – 24 November 2015 – Domino liver transplantation (DLT) with liver grafts from patients with hereditary transthyretin (TTR) amyloidosis has been performed throughout the world because of a severe liver graft shortage. Reports of acquired systemic TTR amyloidosis in domino liver recipients have been increasing; however, the precise pathogenesis and clinical course of acquired TTR amyloidosis remains unclear.